Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Bolt Biotherapeutics revenue
Bolt Biotherapeutics's revenue is $7.7 million.
What is Bolt Biotherapeutics's revenue?
- Bolt Biotherapeutics's revenue growth from 2019 to 2024 is 3,476.74%.
- Bolt Biotherapeutics has 91 employees, and the revenue per employee ratio is $84,505.
- Bolt Biotherapeutics's peak quarterly revenue was $5.3M in 2024(q1).
- Bolt Biotherapeutics peak revenue was $7.9M in 2023.
- Bolt Biotherapeutics annual revenue for 2023 was 7.9M, 37.48% growth from 2022.
- Bolt Biotherapeutics annual revenue for 2024 was 7.7M, -2.36% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Bolt Biotherapeutics historical revenue
Bolt Biotherapeutics's peak revenue was $7.9M in 2023. The peak quarterly revenue was $5.3M in 2024(q1).
Bolt Biotherapeutics's revenue increased from $215.0k in 2019 to $7.7M currently. That's a 3,476.74% change in annual revenue.
Bolt Biotherapeutics annual revenue
Bolt Biotherapeutics annual revenue over time
| Fiscal year / year | Bolt Biotherapeutics revenue |
|---|---|
| 2019 | $215,000 |
| 2020 | $231,000 |
| 2021 | $1.3M |
| 2022 | $5.7M |
| 2023 | $7.9M |
| 2024 | $7.7M |
Rate Bolt Biotherapeutics' financial transparency
Bolt Biotherapeutics annual growth
Bolt Biotherapeutics saw the greatest revenue growth in 2021, when revenue increased by 445.45%.
Bolt Biotherapeutics had the lowest revenue growth in 2020, when revenue changed by 7.44%.
Bolt Biotherapeutics annual growth rate over time
| Year | Bolt Biotherapeutics growth |
|---|---|
| 2020 | 7%↑ |
| 2021 | 445%↑ |
| 2022 | 355%↑ |
| 2023 | 37%↑ |
| 2024 | -2%↓ |
Bolt Biotherapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Bolt Biotherapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | - | $752,000 | $508,000 |
| 2022 | $813,000 | $1.4M | $2.1M | $1.4M |
| 2023 | $1.8M | $1.4M | $2.5M | $2.1M |
| 2024 | $5.3M | $1.3M | $1.1M | - |
Bolt Biotherapeutics jobs nearby
Do you work at Bolt Biotherapeutics?
Is Bolt Biotherapeutics transparent about its revenue structure?
Bolt Biotherapeutics financing
Bolt Biotherapeutics received early financing of $600.0K on 2015-03-06.
| Series | Round size | Date |
|---|---|---|
| Seed | $600K | 03/2015 |
| Series Unknown | $10.0M | 09/2016 |
| Series Unknown | $6M | 02/2018 |
| Series Unknown | $19.4M | 08/2018 |
| Series B | $54M | 02/2019 |
| Series C | $93.5M | 07/2020 |
| Post Ipo Equity | $15M | 06/2021 |
Bolt Biotherapeutics investors
| Investors | Security type |
|---|---|
| Nan Fung Life Sciences | Series B |
| Novo Holdings A | Series B |
| Vivo Capital | Series B |
| PIVOTAL BIOVENTURE PARTNERS | Series B |
| Novo Holdings A | Series C |
| Vivo Capital | Series C |
| SOFINNOVA INVESTMENTS INC | Series C |
| Pfizer Venture Investments | Series C |
| Rock Springs Capital | Series C |
| RA Capital Management | Series C |
| Samsara BioCapital | Series C |
| PIVOTAL BIOVENTURE PARTNERS | Series C |
| Surveyor Capital | Series C |
| Genmab | Post Ipo Equity |
Bolt Biotherapeutics competitors
Bolt Biotherapeutics's top competitor, Xencor, earned an annual revenue of $110.5M.
Bolt Biotherapeutics's smallest competitor is Trillium Therapeutics with revenue of $148.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Eureka Therapeutics | - | $500,000 | 50 | - |
| Immune-Onc Therapeutics | - | $440,000 | 17 | - |
| Trillium Therapeutics | - | $148,000 | 20 | - |
| Immunophotonics | - | $460,000 | 9 | - |
| WindMIL Therapeutics | - | $530,000 | 30 | - |
| Xencor | - | $110.5M | 156 | - |
| Bioniz Therapeutics | - | $1.2M | 30 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Bolt Biotherapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Bolt Biotherapeutics. The employee data is based on information from people who have self-reported their past or current employments at Bolt Biotherapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Bolt Biotherapeutics. The data presented on this page does not represent the view of Bolt Biotherapeutics and its employees or that of Zippia.
Bolt Biotherapeutics may also be known as or be related to BOLT BIOTHERAPEUTICS, INC., Bolt Biotherapeutics and Bolt Biotherapeutics Inc.